A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.

Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these a...

Full description

Bibliographic Details
Main Authors: Payel Ganguly, Landiso Madonsela, Jesse T Chao, Christopher J R Loewen, Timothy P O'Connor, Esther M Verheyen, Douglas W Allan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-09-01
Series:PLoS Genetics
Online Access:https://doi.org/10.1371/journal.pgen.1009774
_version_ 1831715307300847616
author Payel Ganguly
Landiso Madonsela
Jesse T Chao
Christopher J R Loewen
Timothy P O'Connor
Esther M Verheyen
Douglas W Allan
author_facet Payel Ganguly
Landiso Madonsela
Jesse T Chao
Christopher J R Loewen
Timothy P O'Connor
Esther M Verheyen
Douglas W Allan
author_sort Payel Ganguly
collection DOAJ
description Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these assays reproducible, scalable to high numbers of variants, and capable of assessing defined gene-disease mechanism for clinical interpretation aligned to the ClinGen Sequence Variant Interpretation (SVI) Working Group guidelines for 'well-established assays'. Drosophila melanogaster offers great potential as an assay platform, but was untested for high numbers of human variants adherent to these guidelines. Here, we wished to test the utility of Drosophila as a platform for scalable well-established assays. We took a genetic interaction approach to test the function of ~100 human PTEN variants in cancer-relevant suppression of PI3K/AKT signaling in cellular growth and proliferation. We validated the assay using biochemically characterized PTEN mutants as well as 23 total known pathogenic and benign PTEN variants, all of which the assay correctly assigned into predicted functional categories. Additionally, function calls for these variants correlated very well with our recent published data from a human cell line. Finally, using these pathogenic and benign variants to calibrate the assay, we could set readout thresholds for clinical interpretation of the pathogenicity of 70 other PTEN variants. Overall, we demonstrate that Drosophila offers a powerful assay platform for clinical variant interpretation, that can be used in conjunction with other well-established assays, to increase confidence in the accurate assessment of variant function and pathogenicity.
first_indexed 2024-12-21T00:16:39Z
format Article
id doaj.art-5cb487758be84e0eb6cf26744bfaff89
institution Directory Open Access Journal
issn 1553-7390
1553-7404
language English
last_indexed 2024-12-21T00:16:39Z
publishDate 2021-09-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj.art-5cb487758be84e0eb6cf26744bfaff892022-12-21T19:22:13ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042021-09-01179e100977410.1371/journal.pgen.1009774A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.Payel GangulyLandiso MadonselaJesse T ChaoChristopher J R LoewenTimothy P O'ConnorEsther M VerheyenDouglas W AllanGene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these assays reproducible, scalable to high numbers of variants, and capable of assessing defined gene-disease mechanism for clinical interpretation aligned to the ClinGen Sequence Variant Interpretation (SVI) Working Group guidelines for 'well-established assays'. Drosophila melanogaster offers great potential as an assay platform, but was untested for high numbers of human variants adherent to these guidelines. Here, we wished to test the utility of Drosophila as a platform for scalable well-established assays. We took a genetic interaction approach to test the function of ~100 human PTEN variants in cancer-relevant suppression of PI3K/AKT signaling in cellular growth and proliferation. We validated the assay using biochemically characterized PTEN mutants as well as 23 total known pathogenic and benign PTEN variants, all of which the assay correctly assigned into predicted functional categories. Additionally, function calls for these variants correlated very well with our recent published data from a human cell line. Finally, using these pathogenic and benign variants to calibrate the assay, we could set readout thresholds for clinical interpretation of the pathogenicity of 70 other PTEN variants. Overall, we demonstrate that Drosophila offers a powerful assay platform for clinical variant interpretation, that can be used in conjunction with other well-established assays, to increase confidence in the accurate assessment of variant function and pathogenicity.https://doi.org/10.1371/journal.pgen.1009774
spellingShingle Payel Ganguly
Landiso Madonsela
Jesse T Chao
Christopher J R Loewen
Timothy P O'Connor
Esther M Verheyen
Douglas W Allan
A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
PLoS Genetics
title A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_full A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_fullStr A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_full_unstemmed A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_short A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_sort scalable drosophila assay for clinical interpretation of human pten variants in suppression of pi3k akt induced cellular proliferation
url https://doi.org/10.1371/journal.pgen.1009774
work_keys_str_mv AT payelganguly ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT landisomadonsela ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT jessetchao ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT christopherjrloewen ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT timothypoconnor ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT esthermverheyen ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT douglaswallan ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT payelganguly scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT landisomadonsela scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT jessetchao scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT christopherjrloewen scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT timothypoconnor scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT esthermverheyen scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
AT douglaswallan scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation